The SPAC in an amended proxy filing today said shareholders will be asked to vote Jan. 6 for the proposed merger with Clover Health Investments. If approved, Clover is expected to receive up to $728 million of transaction proceeds, and up to $500 million of cash proceeds would be allocated to existing Clover shareholders. Read more.
Social Capital Hedosophia III Sets January Vote on Clover Health
